← All organizations

Breath Therapeutics Inc

For profitWebsite ↗

Also known as: Breath Therapeutics - a Zambon Company | Breath Therapeutics, Chief Medical Officer | Breath Therapeutics Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Feb 29, 2020

Acquired by Zambon on Jul 25, 2019

Timeline

2010s

Jan 1, 2017
Breath Therapeutics Inc— Founded
Jul 25, 2019
Zambon— Acquired By

Drugs by trial phase (1 distinct, 4 trials)

Phase 3 (1 own, 0 via acquisition)

cyclosporine

Indications

Studied for

Recent trials (8)

NCT04039347Lead sponsorPhase 3Feb 29, 2020
NCT04039347Study directorPhase 3Feb 29, 2020
NCT04107675Study directorPhase 2Jan 31, 2020
NCT04107675Lead sponsorPhase 2Jan 31, 2020
NCT03657342Lead sponsorPhase 3Jan 31, 2019
NCT03656926Lead sponsorPhase 3Jan 31, 2019
NCT03656926Study directorPhase 3Jan 31, 2019
NCT03657342Study directorPhase 3Jan 31, 2019

Details

Founded: Munich, DE Jan 1, 2017
Last known activity: Feb 29, 2020